ATE489367T1 - Verfahren und zwischenprodukt zur herstellung von donezepil - Google Patents

Verfahren und zwischenprodukt zur herstellung von donezepil

Info

Publication number
ATE489367T1
ATE489367T1 AT07700316T AT07700316T ATE489367T1 AT E489367 T1 ATE489367 T1 AT E489367T1 AT 07700316 T AT07700316 T AT 07700316T AT 07700316 T AT07700316 T AT 07700316T AT E489367 T1 ATE489367 T1 AT E489367T1
Authority
AT
Austria
Prior art keywords
donezepil
producing
intermediate product
relates
compounds
Prior art date
Application number
AT07700316T
Other languages
English (en)
Inventor
Srinivas Pathi
Vinod Acharya
Dharmaraj Rao
Rajendra Kankan
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Application granted granted Critical
Publication of ATE489367T1 publication Critical patent/ATE489367T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT07700316T 2006-01-04 2007-01-03 Verfahren und zwischenprodukt zur herstellung von donezepil ATE489367T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN17MU2006 2006-01-04
PCT/GB2007/000009 WO2007077443A1 (en) 2006-01-04 2007-01-03 Process and intermediate for preparation of donepezil

Publications (1)

Publication Number Publication Date
ATE489367T1 true ATE489367T1 (de) 2010-12-15

Family

ID=37728502

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07700316T ATE489367T1 (de) 2006-01-04 2007-01-03 Verfahren und zwischenprodukt zur herstellung von donezepil

Country Status (11)

Country Link
US (1) US8030491B2 (de)
EP (1) EP1973878B1 (de)
JP (1) JP2009524599A (de)
KR (1) KR20080085195A (de)
AT (1) ATE489367T1 (de)
AU (1) AU2007203969B2 (de)
CA (1) CA2635550A1 (de)
DE (1) DE602007010725D1 (de)
ES (1) ES2354737T3 (de)
NZ (1) NZ569532A (de)
WO (1) WO2007077443A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080085195A (ko) 2006-01-04 2008-09-23 씨아이피엘에이 엘티디. 도네페질의 제조방법 및 중간체
US20100113793A1 (en) * 2006-03-20 2010-05-06 Ind-Swift Laboratories Limited Process for the Preparation of Highly Pure Donepezil
EP2114166A4 (de) 2006-12-11 2011-05-25 Reviva Pharmaceuticals Inc Zusammensetzungen, synthese und verfahren zur verwendung indanonbasierter cholinesterase-hemmer
KR101062073B1 (ko) 2008-09-04 2011-09-02 주식회사종근당 도네페질, 염산도네페질 및 그의 중간체의 신규 제조방법
EP2366378A1 (de) 2010-03-01 2011-09-21 Dexcel Pharma Technologies Ltd. Donepezilformulierungen mit verzögerter Freisetzung
WO2012038966A1 (en) 2010-09-22 2012-03-29 Tyche Industries Ltd. Process for the preparation of donepezil intermediate
CN103524515B (zh) 2012-07-03 2016-07-06 浙江海正药业股份有限公司 具有乙酰胆碱酯酶抑制活性的苯并间二氧杂环戊烯衍生物及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
AU716462B2 (en) * 1995-12-15 2000-02-24 Pfizer Inc. Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine
IL125809A (en) 1998-08-17 2005-08-31 Finetech Lab Ltd Process and intermediates for production of donepezil and related compounds
US20050239837A1 (en) * 2002-08-14 2005-10-27 Gutman Arie L Process for production of highly pure donepezil hydrochloride
JP4544999B2 (ja) * 2002-11-25 2010-09-15 持田製薬株式会社 4−ヒドロキシピペリジン誘導体を有効成分とする呼吸器疾患治療剤
JP2004217639A (ja) * 2002-12-24 2004-08-05 Eisai Co Ltd アルツハイマー病治療剤
US6953856B2 (en) * 2003-02-12 2005-10-11 Usv, Limited Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
EP1654230A1 (de) * 2003-07-01 2006-05-10 Hetero Drugs Limited Herstellung von zwischenprodukten für acetylcholinesteraseinhibitoren
CA2552221A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Donepezil formulations
CN1300112C (zh) * 2004-01-06 2007-02-14 浙江大学 N-苄基-4-哌啶基甲醛的合成方法
WO2005076749A2 (en) * 2004-02-11 2005-08-25 Jubilant Organosys Limited A novel process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine
KR20080085195A (ko) 2006-01-04 2008-09-23 씨아이피엘에이 엘티디. 도네페질의 제조방법 및 중간체

Also Published As

Publication number Publication date
JP2009524599A (ja) 2009-07-02
US8030491B2 (en) 2011-10-04
EP1973878B1 (de) 2010-11-24
NZ569532A (en) 2010-11-26
DE602007010725D1 (de) 2011-01-05
AU2007203969A1 (en) 2007-07-12
WO2007077443A1 (en) 2007-07-12
KR20080085195A (ko) 2008-09-23
AU2007203969B2 (en) 2012-04-05
ES2354737T3 (es) 2011-03-17
EP1973878A1 (de) 2008-10-01
CA2635550A1 (en) 2007-07-12
US20090187020A1 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
EA200701176A1 (ru) Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
CY1123658T1 (el) Μεθοδος για τη δημιουργια χημικων ενωσεων κινολονης
MY150596A (en) Hsp90 inhibitors
MX2011009127A (es) Nicotinamidas sustituidas como moduladores de kcnq2/3.
ATE477234T1 (de) Synthese von phenolischen estern von hydroxymethylphenolen
TW201129564A (en) Diphenylpyrazolopyridine derivatives, preparation thereof and therapeutic use thereof
MX2009009238A (es) Nuevos inhibidores de fosfodiesterasa.
ATE553083T1 (de) Verfahren zur herstellung eines 2- pyridylethylcarbonsäureamidderivats
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
MX2009004343A (es) Compuestos organicos.
MY151211A (en) 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds
DE602007010725D1 (de) Verfahren und zwischenprodukt zur herstellung von donezepil
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
DK1513800T3 (da) Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
ATE343385T1 (de) Verfahren zur herstellung von donepezil
ATE532516T1 (de) Verfahren zur synthese von glyt-1-hemmern
ATE441627T1 (de) Verfahren zur herstellung von valsartan
TW200635905A (en) Processes for producing 4-aminoquinazolines
EP2604261A3 (de) SCCA-1-Produktionshemmer mit einem Carboxamidderivat und/oder einem Salz daraus als Wirkstoff
BRPI0516192A (pt) composto, e, método para a preparação de um composto
ATE555093T1 (de) Verfahren zur herstellung einer (s)-1-alkyl-2i,6i-pipecoloxylididverbindung
TW200736218A (en) Method for producing tertiary amines
DE602004014822D1 (de) Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
UA106595C2 (uk) Спосіб одержання празугрелю
ATE466010T1 (de) Verfahren zur herstellung von candesartan

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties